Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Nexalin Technologies (NXLIW)

Nexalin Technologies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NXLIW
DateTimeSourceHeadlineSymbolCompany
14/01/202513:30GlobeNewswire Inc.Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025NASDAQ:NXLIWNexalin Technologies Inc
10/01/202521:35Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NXLIWNexalin Technologies Inc
23/12/202415:00GlobeNewswire Inc.Nexalin Technology Completes Phase 1of its Innovative Virtual ClinicNASDAQ:NXLIWNexalin Technologies Inc
20/12/202417:35Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:NXLIWNexalin Technologies Inc
26/11/202415:00GlobeNewswire Inc.New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation MarketNASDAQ:NXLIWNexalin Technologies Inc
11/11/202413:00GlobeNewswire Inc.Nexalin Technology CEO Provides Letter to ShareholdersNASDAQ:NXLIWNexalin Technologies Inc
08/11/202421:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NXLIWNexalin Technologies Inc
01/11/202418:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXLIWNexalin Technologies Inc
01/11/202418:00GlobeNewswire Inc.Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5thNASDAQ:NXLIWNexalin Technologies Inc
01/11/202414:34GlobeNewswire Inc.Nexalin Technology Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:NXLIWNexalin Technologies Inc
30/10/202414:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXLIWNexalin Technologies Inc
28/10/202412:30GlobeNewswire Inc.Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's DiseaseNASDAQ:NXLIWNexalin Technologies Inc
22/10/202418:15GlobeNewswire Inc.Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VANASDAQ:NXLIWNexalin Technologies Inc
17/10/202412:30GlobeNewswire Inc.New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s PatientsNASDAQ:NXLIWNexalin Technologies Inc
14/10/202412:30GlobeNewswire Inc.Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory AffairsNASDAQ:NXLIWNexalin Technologies Inc
02/10/202418:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXLIWNexalin Technologies Inc
19/09/202420:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXLIWNexalin Technologies Inc
05/09/202413:00GlobeNewswire Inc.Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid TreatmentNASDAQ:NXLIWNexalin Technologies Inc
18/07/202412:30GlobeNewswire Inc.Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use RecoveryNASDAQ:NXLIWNexalin Technologies Inc
01/07/202418:45GlobeNewswire Inc.Nexalin Technology Announces Closing of $5.2 Million Public OfferingNASDAQ:NXLIWNexalin Technologies Inc
28/06/202401:15GlobeNewswire Inc.Nexalin Technology Announces Pricing of $5.2 Million Public OfferingNASDAQ:NXLIWNexalin Technologies Inc
26/06/202413:00GlobeNewswire Inc.Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific JournalNASDAQ:NXLIWNexalin Technologies Inc
20/06/202412:30GlobeNewswire Inc.Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and DementiaNASDAQ:NXLIWNexalin Technologies Inc
18/06/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXLIWNexalin Technologies Inc
14/06/202413:53Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NXLIWNexalin Technologies Inc
13/06/202419:00GlobeNewswire Inc.Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)NASDAQ:NXLIWNexalin Technologies Inc
12/06/202417:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXLIWNexalin Technologies Inc
04/06/202412:30GlobeNewswire Inc.Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6thNASDAQ:NXLIWNexalin Technologies Inc
03/06/202412:30GlobeNewswire Inc.FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset DeviceNASDAQ:NXLIWNexalin Technologies Inc
23/05/202421:17Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:NXLIWNexalin Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:NXLIW

Your Recent History

Delayed Upgrade Clock